Dow Pares Some Gains, but Signs of Economic Recovery Keep Bulls Alive

Investing.com

Published Jun 16, 2020 03:24PM ET

Updated Jun 16, 2020 04:01PM ET

By Yasin Ebrahim

Investing.com - The Dow closed higher despite paring some gains Tuesday, as investor sentiment was lifted by data suggesting the economy is on the road to recovery, but gains were kept in check by lingering fears a second wave of the Covid-19 pandemic could be ahead following a sharp uptick in infections in the U.S. and other parts of the world. 

The Dow Jones Industrial Average rose 2%, or 526 points, though had climbed by 838 points intraday. The S&P 500 gained 1.91%, while the Nasdaq Composite added 1.8%.

Retail sales surged 17.7% in May, rebounding from a record slump in April. The better-than-expected data suggested that consumer spending is on the mend, though some on Wall Street remained wary over whether the momentum was likely to continue.

"The comeback was much faster than expected, and looks like a beginning of a v-shaped recovery in consumer spending. That's assuming the positive momentum is sustained, something we remain skeptical about," Jefferies (NYSE:JEF) said in a note.

Retailers including Macy’s (NYSE:M), Gap (NYSE:GPS) and Nordstrom (NYSE:JWN) surged on the back of the strong retail sales report.

Monetary policy was also in focus as Federal Reserve chairman Jerome Powell cooled some hopes that the central bank's corporate bond-buying program, which kicked off today, would be aggressive.

Powell also touted signs of a recovery, though continued to stress that the outlook remains uncertain amid a lack of visibility about the trajectory of the disease. "Until the public is confident that the disease is contained, a full recovery is unlikely."

Virus hospitalizations in Texas rose 8.3% overnight to hit a record. Florida’s Department of Health on Tuesday reported that daily infections rose 2,783 overnight to a record high in the state.

In China, meanwhile, a wave of infections in Beijing forced the government to impose stricter measures, including the shut down of all schools, to curb the outbreak. 

Hopes of an effective coronavirus treatment were given a boost, meanwhile, after researchers in the U.K. released clinical data showing that steroid, Dexamethasone, had reduced deaths among the sickest Covid-19 patients.  Dexamethasone reduced the death rate of patients on a ventilator by 35%, and by 20% for patients who needed oxygen but were not ventilated, according to the study. 

The results were "very positive," but still need to be validated, Scott Gottlieb, a former commissioner of the U.S. Food and Drug Administration, told CNBC.   

Energy led the broader market gains, underpinned by a rise in oil prices after the International Energy Agency lifted its oil demand forecast for 2020.  

The IEA upgraded its estimate on oil demand to 91.7 million barrels per day (bpd) in 2020, 500,000 bpd higher than its previous forecast.

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

In technology, Apple (NASDAQ:AAPL) climbed 2.6% after Citigroup (NYSE:C) increased its price target on the stock to $400 per share from $310 per share, citing numerous tailwinds, including upside from tech giant's wearables business.

Elsewhere, industrials and construction stocks were pushed higher on reports that the Trump administration is preparing $1 trillion infrastructure program to spur economic growth.

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes